期刊文献+

孕妇血浆中游离胎儿DNA测定在产前诊断中的应用 被引量:2

原文传递
导出
摘要 传统的羊膜腔穿刺和绒毛吸取是目前许多医院较为常用的产前诊断技术,因其操作易导致流产、胎儿损伤或死亡、宫内感染、羊膜破裂等,使其在临床上的推广和应用受到了限制。利用孕妇外周血中的胎儿细胞进行遗传学诊断一直是无创性产前诊断的重要探索途径。但由于孕妇外周血中的胎儿细胞数量少,而且存在个体差异,目前很难从外周血中分离出完整的胎儿细胞,这无疑限制了这种方法在临床上的应用。1997年,有学者研究发现,孕妇血液循环中存在较丰富的游离胎儿DNA,这一发现为无创性产前诊断和筛查开辟了新领域。
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2006年第7期492-494,共3页 Chinese Journal of Obstetrics and Gynecology
  • 相关文献

参考文献26

  • 1Guetta E, Simchen MJ, Mammon-Daviko K,et al. Analysis of fetal blood cells in the maternal circulation: challenges, ongoing efforts,and potential solutions. Stem-Cells-Dev ,2004,13:93-99.
  • 2Simpson JL, Bischoff F. Cell-free fetal DNA in maternal blood:evolving clinical applications. JAMA ,2004,291 : 1135-1137.
  • 3Chiu RW, Lo YM. Recent developments in fetal DNA in maternal plasma. Ann N Y Acad Sci, 2004,1022:100-104.
  • 4Rijnders RJ, Christiaens GC, Bossers B, et al. Clinical applications of cell-free fetal DNA from maternal plasma. Obstet Gynecol, 2004,103 : 157-164.
  • 5Harper TC, Finning KM, Martin P, et al. Use of maternal plasma for noninvasive determination of fetal RhD status. Am J Obstet Gynecol,2004,191 : 1730-1732.
  • 6Lo YM, Lau TK, Zhang J,et al. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21.Clin Chem,1999, 45 : 1747-1751.
  • 7Farina A, LeShane ES, Lambert-Messerlian GM, et al. Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy. Clin Chem, 2003, 49: 239-242.
  • 8Wataganara T, LeShane ES, Farina T, et al. Maternal serum cell-free fetal DNA levels are increased in cases of trisomy 13 but not trisomy 18. Hum Genet, 2003, 112: 204-208.
  • 9Sailer DN, Canick JA, Blitzer MG, et al. Second-trimester maternal serum analyte levels associated with fetal trisomy 13. Prenat Diagn,1999,19:813-816.
  • 10Lo YM, Leung TN, Tein MS, et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem, 1999, 45:184-188.

同被引文献18

  • 1Swaminathan R,Butt AN. Circulating nucleic acids in plasma and ser- um Recent developments[J]. Ann N Y Acad Sci, 2006,1075 : 1 9.
  • 2Dennis Lo YM, Chiu RW. Prenatal diagnosis: Pprogress through plasma nucleic acids[J]. Nat Rev Genet, 2007,8 (1) : 71-77.
  • 3Lo YM, Patel P, Wainscoat JS, et al. Prenatal sexdeterrnination by DNA amplification from maternal peripheral blood[J]. Lancet, 1989,2 (8676) :1363-1365.
  • 4Lo YM, Corbetta N, Chamberlain PF, et al . Presence of fetal DNA in maternal plasma and serum[J]. Lancet, 1997,350(9076) :485-487.
  • 5Chan KC, Zhang J, Hui AB, et al. Size distributions of maternal and fetal DNA in maternal plasma[J]. Clin Chem,2004,50(1) 88-92.
  • 6Hill M, Barrett AN,White H, et al. Uses of cell free fetal DNA in materna/circulation[J]. Best Pract Res Clin Obstet Gynaecol,2012, 26(5) :639 654.
  • 7Poon LL, Leung TN, Lau TK, et al. Differential DNA rnethylation be- tween fetus and mother as a strategy for detecting fetal DNA inma- ternal plasma[J]. Clin Chem,2002,48(1):35-41.
  • 8Chim SS,Tong YK,Chiu RW,et al. Detection of the placental epige- netic signature of the rnaspin gene in maternal plasma[J]. Proc Natl Acad Sci USA, 2005,102(4,1) : 14 753-14 758.
  • 9Benachi A, Delahaye S, Lcticee N, et al. Impact of non-invasive fetal RhD genotyping on management costs of rhesuD negative patients: Results of a French pilot study[J]. Eur J Obstet Gynecol Reprod Biol,2012,162(1) :28-32.
  • 10Oudejans CB,Go AT, Visser A, et a l . Detection of chromosome 21- encoded mRNA of placental origin in maternal plasma [J]. Clin Chem, 2003,49(9) : 1445-1449.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部